These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32910944)

  • 1. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
    Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD
    Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringin: Cardioprotective properties and safety profile in diabetes treatment.
    Yaseen HS; Zubair HM; Jamal A; Farrukh M; Mikrani R; Shaukat B; Hill JW; Rana R; Nazir A; Naveed M; Malik S
    Fitoterapia; 2024 Jul; 176():106011. PubMed ID: 38740344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
    Hernández-Aquino E; Muriel P
    World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.
    Nyane NA; Tlaila TB; Malefane TG; Ndwandwe DE; Owira PMO
    Eur J Pharmacol; 2017 May; 803():103-111. PubMed ID: 28322845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.
    Zeng X; Su W; Liu B; Chai L; Shi R; Yao H
    Mini Rev Med Chem; 2020; 20(4):286-293. PubMed ID: 32134369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.
    Hsiu SL; Huang TY; Hou YC; Chin DH; Chao PD
    Life Sci; 2002 Feb; 70(13):1481-9. PubMed ID: 11895099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging potential of citrus flavanones as an antioxidant in diabetes and its complications.
    Sharma M; Akhtar N; Sambhav K; Shete G; Bansal AK; Sharma SS
    Curr Top Med Chem; 2015; 15(2):187-95. PubMed ID: 25547100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated flavonoids as anti-seizure agents: Naringenin 4',7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models.
    Copmans D; Orellana-Paucar AM; Steurs G; Zhang Y; Ny A; Foubert K; Exarchou V; Siekierska A; Kim Y; De Borggraeve W; Dehaen W; Pieters L; de Witte PAM
    Neurochem Int; 2018 Jan; 112():124-133. PubMed ID: 29174382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction.
    Ishii K; Furuta T; Kasuya Y
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):299-305. PubMed ID: 9518163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu).
    Guo D; Wang J; Wang X; Luo H; Zhang H; Cao D; Chen L; Huang N
    J Ethnopharmacol; 2011 Nov; 138(2):451-7. PubMed ID: 21964193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
    Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
    Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringin protects against lipopolysaccharide-induced cardiac injury in mice.
    Xianchu L; Lan PZ; Qiufang L; Yi L; Xiangcheng R; Wenqi H; Yang D
    Environ Toxicol Pharmacol; 2016 Dec; 48():1-6. PubMed ID: 27716530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin and Naringenin: Potential Multi-Target Agents for Alzheimer's Disease.
    Lu J; Chen J; Li SY; Pan GJ; Ou Y; Yuan LF; Jiang JP; Zeng LH; Zhao J
    Curr Med Sci; 2024 Oct; 44(5):867-882. PubMed ID: 39347923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of naringin and naringenin on endotoxin-induced uveitis in rats.
    Shiratori K; Ohgami K; Ilieva I; Jin XH; Yoshida K; Kase S; Ohno S
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):298-304. PubMed ID: 16117693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat.
    Chtourou Y; Aouey B; Aroui S; Kebieche M; Fetoui H
    Chem Biol Interact; 2016 Jan; 243():1-9. PubMed ID: 26612654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae.
    Gerçek E; Zengin H; Erdem Erişir F; Yılmaz Ö
    Comp Biochem Physiol C Toxicol Pharmacol; 2021 Mar; 241():108969. PubMed ID: 33412300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.